Lyell Immunopharma shares owned by Citigroup
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $95k | 48k | 2.00 |
| 2023-12-31 | $147k | 76k | 1.94 |
| 2023-09-30 | $285k | 194k | 1.47 |
| 2023-03-31 | $984k | 417k | 2.36 |
| 2022-12-31 | $939k | 271k | 3.47 |
| 2022-09-30 | $1.5M | 207k | 7.33 |
| 2021-12-31 | $368k | 48k | 7.75 |